Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3nwb | 659 | Catechol O-methyltransferase | 2.1.1.6 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3nwb | 659 | Catechol O-methyltransferase | 2.1.1.6 | 1.000 | |
| 3nwe | 662 | Catechol O-methyltransferase | 2.1.1.6 | 0.619 | |
| 1jr4 | CL4 | Catechol O-methyltransferase | 2.1.1.6 | 0.600 | |
| 2zvj | KOM | Catechol O-methyltransferase | 2.1.1.6 | 0.598 | |
| 3a7d | FBN | Catechol O-methyltransferase | 2.1.1.6 | 0.579 | |
| 3hvk | 719 | Catechol O-methyltransferase | 2.1.1.6 | 0.577 | |
| 3nw9 | 637 | Catechol O-methyltransferase | 2.1.1.6 | 0.571 | |
| 3ozs | OZS | Catechol O-methyltransferase | 2.1.1.6 | 0.563 | |
| 5fhq | DNC | Catechol O-methyltransferase | 2.1.1.6 | 0.560 | |
| 3hvi | 619 | Catechol O-methyltransferase | 2.1.1.6 | 0.553 | |
| 3ozt | OZZ | Catechol O-methyltransferase | 2.1.1.6 | 0.541 | |
| 3r6t | LU1 | Catechol O-methyltransferase | 2.1.1.6 | 0.525 | |
| 3oe4 | 610 | Catechol O-methyltransferase | 2.1.1.6 | 0.508 | |
| 3ozr | OZR | Catechol O-methyltransferase | 2.1.1.6 | 0.498 | |
| 4i9z | 5BA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.468 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.464 | |
| 3d4b | DZD | NAD-dependent protein deacetylase | / | 0.462 | |
| 2zth | SAM | Catechol O-methyltransferase | 2.1.1.6 | 0.459 | |
| 3lga | SAH | tRNA (adenine(57)-N(1)/adenine(58)-N(1))-methyltransferase TrmI | 2.1.1.219 | 0.457 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 2qcu | FAD | Aerobic glycerol-3-phosphate dehydrogenase | 1.1.5.3 | 0.452 | |
| 1rd4 | L08 | Integrin alpha-L | / | 0.450 | |
| 1xp6 | AIU | Estrogen receptor | / | 0.448 | |
| 1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.447 | |
| 1rfq | LAR | Actin, alpha skeletal muscle | / | 0.447 | |
| 3eon | 341 | Glutaryl-CoA dehydrogenase | / | 0.447 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 3oe5 | 611 | Catechol O-methyltransferase | 2.1.1.6 | 0.446 | |
| 3bgi | SAH | Thiopurine S-methyltransferase | 2.1.1.67 | 0.445 | |
| 3h4v | DVP | Pteridine reductase 1 | 1.5.1.33 | 0.445 | |
| 3w8w | FAD | Putative FAD-dependent oxygenase EncM | / | 0.445 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 4phl | PIL | Phosphodiesterase | / | 0.444 | |
| 3bgv | SAH | mRNA cap guanine-N7 methyltransferase | 2.1.1.56 | 0.443 | |
| 3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 2rhr | EMO | Putative ketoacyl reductase | 1.3.1 | 0.441 | |
| 5e8j | SAH | mRNA cap guanine-N7 methyltransferase | 2.1.1.56 | 0.441 | |
| 1kyx | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.440 | |
| 1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.440 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.440 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 |